| ACT | Adoptive cell therapy |
| CAFs | Cancer-associated fibroblasts |
| CAR | Chimeric antigen receptor |
| DDR | Discoidin domain-containing receptor |
| EC-BM | Endothelial basement membrane |
| ECM | Extracellular matrix |
| FGFs | Fibroblast growth factors |
| HPSE | Heparanase |
| HSPG | Heparan sulfate proteoglycans |
| ICAM1 | Integrin ligands intercellular adhesion molecule 1 |
| ICB | Immune checkpoint blockade |
| LOX | Lysyl oxidases |
| MAdCAM-1 | Mucosal vascular addressin cell adhesion molecule 1 |
| POSTN | Periostin |
| PDGF-B | Platelet-derived growth factor-B |
| TIME | Tumor immune microenvironment |
| TILs | Tumor-infiltrating lymphocytes |
| TNBC | Triple-negative breast cancer |
| TNF-α | Tumor necrosis factor-α |
| TME | Tumor microenvironment |
| VEGFs | Vascular endothelial growth factors |
| VCAM1 | Vascular cell adhesion protein 1 |